Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
editorial
. 1991 Oct;64(4):617–620. doi: 10.1038/bjc.1991.372

Epithelial ovarian cancer: a cytokine propelled disease?

S Malik, F Balkwill
PMCID: PMC1977678  PMID: 1911209

Full text

PDF
617

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balkwill F. R., Burke F. The cytokine network. Immunol Today. 1989 Sep;10(9):299–304. doi: 10.1016/0167-5699(89)90085-6. [DOI] [PubMed] [Google Scholar]
  2. Bartocci A., Pollard J. W., Stanley E. R. Regulation of colony-stimulating factor 1 during pregnancy. J Exp Med. 1986 Sep 1;164(3):956–961. doi: 10.1084/jem.164.3.956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bottazzi B., Colotta F., Sica A., Nobili N., Mantovani A. A chemoattractant expressed in human sarcoma cells (tumor-derived chemotactic factor, TDCF) is identical to monocyte chemoattractant protein-1/monocyte chemotactic and activating factor (MCP-1/MCAF). Int J Cancer. 1990 Apr 15;45(4):795–797. doi: 10.1002/ijc.2910450436. [DOI] [PubMed] [Google Scholar]
  4. Bottazzi B., Ghezzi P., Taraboletti G., Salmona M., Colombo N., Bonazzi C., Mangioni C., Mantovani A. Tumor-derived chemotactic factor(s) from human ovarian carcinoma: evidence for a role in the regulation of macrophage content of neoplastic tissues. Int J Cancer. 1985 Aug 15;36(2):167–173. doi: 10.1002/ijc.2910360207. [DOI] [PubMed] [Google Scholar]
  5. Brenner D. A., O'Hara M., Angel P., Chojkier M., Karin M. Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha. Nature. 1989 Feb 16;337(6208):661–663. doi: 10.1038/337661a0. [DOI] [PubMed] [Google Scholar]
  6. Casagrande J. T., Louie E. W., Pike M. C., Roy S., Ross R. K., Henderson B. E. "Incessant ovulation" and ovarian cancer. Lancet. 1979 Jul 28;2(8135):170–173. doi: 10.1016/s0140-6736(79)91435-1. [DOI] [PubMed] [Google Scholar]
  7. Cramer D. W., Welch W. R. Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst. 1983 Oct;71(4):717–721. [PubMed] [Google Scholar]
  8. Cruickshank D. J. Aetiological importance of ovulation in epithelial ovarian cancer: a population based study. BMJ. 1990 Sep 15;301(6751):524–525. doi: 10.1136/bmj.301.6751.524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Darling G., Fraker D. L., Jensen J. C., Gorschboth C. M., Norton J. A. Cachectic effects of recombinant human tumor necrosis factor in rats. Cancer Res. 1990 Jul 1;50(13):4008–4013. [PubMed] [Google Scholar]
  10. Demetri G. D., Ernst T. J., Pratt E. S., 2nd, Zenzie B. W., Rheinwald J. G., Griffin J. D. Expression of ras oncogenes in cultured human cells alters the transcriptional and posttranscriptional regulation of cytokine genes. J Clin Invest. 1990 Oct;86(4):1261–1269. doi: 10.1172/JCI114833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dvorak H. F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med. 1986 Dec 25;315(26):1650–1659. doi: 10.1056/NEJM198612253152606. [DOI] [PubMed] [Google Scholar]
  12. Erroi A., Sironi M., Chiaffarino F., Chen Z. G., Mengozzi M., Mantovani A. IL-1 and IL-6 release by tumor-associated macrophages from human ovarian carcinoma. Int J Cancer. 1989 Nov 15;44(5):795–801. doi: 10.1002/ijc.2910440508. [DOI] [PubMed] [Google Scholar]
  13. Fathalla M. F. Incessant ovulation--a factor in ovarian neoplasia? Lancet. 1971 Jul 17;2(7716):163–163. doi: 10.1016/s0140-6736(71)92335-x. [DOI] [PubMed] [Google Scholar]
  14. Fràter-Schröder M., Risau W., Hallmann R., Gautschi P., Böhlen P. Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5277–5281. doi: 10.1073/pnas.84.15.5277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Giavazzi R., Garofalo A., Bani M. R., Abbate M., Ghezzi P., Boraschi D., Mantovani A., Dejana E. Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice. Cancer Res. 1990 Aug 1;50(15):4771–4775. [PubMed] [Google Scholar]
  16. Hajjar K. A., Hajjar D. P., Silverstein R. L., Nachman R. L. Tumor necrosis factor-mediated release of platelet-derived growth factor from cultured endothelial cells. J Exp Med. 1987 Jul 1;166(1):235–245. doi: 10.1084/jem.166.1.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Haranaka K., Satomi N., Sakurai A. Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice. Int J Cancer. 1984 Aug 15;34(2):263–267. doi: 10.1002/ijc.2910340219. [DOI] [PubMed] [Google Scholar]
  18. Hudziak R. M., Lewis G. D., Shalaby M. R., Eessalu T. E., Aggarwal B. B., Ullrich A., Shepard H. M. Amplified expression of the HER2/ERBB2 oncogene induces resistance to tumor necrosis factor alpha in NIH 3T3 cells. Proc Natl Acad Sci U S A. 1988 Jul;85(14):5102–5106. doi: 10.1073/pnas.85.14.5102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ito A., Sato T., Iga T., Mori Y. Tumor necrosis factor bifunctionally regulates matrix metalloproteinases and tissue inhibitor of metalloproteinases (TIMP) production by human fibroblasts. FEBS Lett. 1990 Aug 20;269(1):93–95. doi: 10.1016/0014-5793(90)81127-a. [DOI] [PubMed] [Google Scholar]
  20. Kacinski B. M., Carter D., Mittal K., Yee L. D., Scata K. A., Donofrio L., Chambers S. K., Wang K. I., Yang-Feng T., Rohrschneider L. R. Ovarian adenocarcinomas express fms-complementary transcripts and fms antigen, often with coexpression of CSF-1. Am J Pathol. 1990 Jul;137(1):135–147. [PMC free article] [PubMed] [Google Scholar]
  21. Kacinski B. M., Stanley E. R., Carter D., Chambers J. T., Chambers S. K., Kohorn E. I., Schwartz P. E. Circulating levels of CSF-1 (M-CSF) a lymphohematopoietic cytokine may be a useful marker of disease status in patients with malignant ovarian neoplasms. Int J Radiat Oncol Biol Phys. 1989 Jul;17(1):159–164. doi: 10.1016/0360-3016(89)90383-0. [DOI] [PubMed] [Google Scholar]
  22. Kindler V., Sappino A. P., Grau G. E., Piguet P. F., Vassalli P. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell. 1989 Mar 10;56(5):731–740. doi: 10.1016/0092-8674(89)90676-4. [DOI] [PubMed] [Google Scholar]
  23. Kishimoto T. The biology of interleukin-6. Blood. 1989 Jul;74(1):1–10. [PubMed] [Google Scholar]
  24. Knupp C., Pekala P. H., Cornelius P. Extensive bone marrow necrosis in patients with cancer and tumor necrosis factor activity in plasma. Am J Hematol. 1988 Dec;29(4):215–221. doi: 10.1002/ajh.2830290408. [DOI] [PubMed] [Google Scholar]
  25. Le J., Vilcek J. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab Invest. 1987 Mar;56(3):234–248. [PubMed] [Google Scholar]
  26. Lee J. H., Kavanagh J. J., Wildrick D. M., Wharton J. T., Blick M. Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas. Cancer Res. 1990 May 1;50(9):2724–2728. [PubMed] [Google Scholar]
  27. Lindemann A., Ludwig W. D., Oster W., Mertelsmann R., Herrmann F. High-level secretion of tumor necrosis factor-alpha contributes to hematopoietic failure in hairy cell leukemia. Blood. 1989 Mar;73(4):880–884. [PubMed] [Google Scholar]
  28. Malik S. T., Griffin D. B., Fiers W., Balkwill F. R. Paradoxical effects of tumour necrosis factor in experimental ovarian cancer. Int J Cancer. 1989 Nov 15;44(5):918–925. doi: 10.1002/ijc.2910440529. [DOI] [PubMed] [Google Scholar]
  29. Malik S. T., Naylor M. S., East N., Oliff A., Balkwill F. R. Cells secreting tumour necrosis factor show enhanced metastasis in nude mice. Eur J Cancer. 1990;26(10):1031–1034. doi: 10.1016/0277-5379(90)90044-t. [DOI] [PubMed] [Google Scholar]
  30. Motro B., Itin A., Sachs L., Keshet E. Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis. Proc Natl Acad Sci U S A. 1990 Apr;87(8):3092–3096. doi: 10.1073/pnas.87.8.3092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Naylor M. S., Malik S. T., Stamp G. W., Jobling T., Balkwill F. R. In situ detection of tumour necrosis factor in human ovarian cancer specimens. Eur J Cancer. 1990;26(10):1027–1030. doi: 10.1016/0277-5379(90)90043-s. [DOI] [PubMed] [Google Scholar]
  32. Niitsu Y., Watanabe N., Neda H., Yamauchi N., Maeda M., Sone H., Kuriyama H. Induction of synthesis of tumor necrosis factor in human and murine cell lines by exogenous recombinant human tumor necrosis factor. Cancer Res. 1988 Oct 1;48(19):5407–5410. [PubMed] [Google Scholar]
  33. Oliff A., Defeo-Jones D., Boyer M., Martinez D., Kiefer D., Vuocolo G., Wolfe A., Socher S. H. Tumors secreting human TNF/cachectin induce cachexia in mice. Cell. 1987 Aug 14;50(4):555–563. doi: 10.1016/0092-8674(87)90028-6. [DOI] [PubMed] [Google Scholar]
  34. Ozols R. F., Garvin A. J., Costa J., Simon R. M., Young R. C. Advanced ovarian cancer: correlation of histologic grade with response to therapy and survival. Cancer. 1980 Feb;45(3):572–581. doi: 10.1002/1097-0142(19800201)45:3<572::aid-cncr2820450325>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  35. Philip R., Epstein L. B. Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1. Nature. 1986 Sep 4;323(6083):86–89. doi: 10.1038/323086a0. [DOI] [PubMed] [Google Scholar]
  36. Pober J. S. Effects of tumour necrosis factor and related cytokines on vascular endothelial cells. Ciba Found Symp. 1987;131:170–184. doi: 10.1002/9780470513521.ch12. [DOI] [PubMed] [Google Scholar]
  37. Postlethwaite A. E., Seyer J. M. Stimulation of fibroblast chemotaxis by human recombinant tumor necrosis factor alpha (TNF-alpha) and a synthetic TNF-alpha 31-68 peptide. J Exp Med. 1990 Dec 1;172(6):1749–1756. doi: 10.1084/jem.172.6.1749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Ralston S. H., Russell R. G., Gowen M. Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women. J Bone Miner Res. 1990 Sep;5(9):983–988. doi: 10.1002/jbmr.5650050912. [DOI] [PubMed] [Google Scholar]
  39. Ramakrishnan S., Xu F. J., Brandt S. J., Niedel J. E., Bast R. C., Jr, Brown E. L. Constitutive production of macrophage colony-stimulating factor by human ovarian and breast cancer cell lines. J Clin Invest. 1989 Mar;83(3):921–926. doi: 10.1172/JCI113977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Rice G. E., Gimbrone M. A., Jr, Bevilacqua M. P. Tumor cell-endothelial interactions. Increased adhesion of human melanoma cells to activated vascular endothelium. Am J Pathol. 1988 Nov;133(2):204–210. [PMC free article] [PubMed] [Google Scholar]
  41. Sato K., Fujii Y., Ono M., Nomura H., Shizume K. Production of interleukin 1 alpha-like factor and colony-stimulating factor by a squamous cell carcinoma of the thyroid (T3M-5) derived from a patient with hypercalcemia and leukocytosis. Cancer Res. 1987 Dec 15;47(24 Pt 1):6474–6480. [PubMed] [Google Scholar]
  42. Silverberg E., Boring C. C., Squires T. S. Cancer statistics, 1990. CA Cancer J Clin. 1990 Jan-Feb;40(1):9–26. [PubMed] [Google Scholar]
  43. Slamon D. J., Godolphin W., Jones L. A., Holt J. A., Wong S. G., Keith D. E., Levin W. J., Stuart S. G., Udove J., Ullrich A. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science. 1989 May 12;244(4905):707–712. doi: 10.1126/science.2470152. [DOI] [PubMed] [Google Scholar]
  44. Spriggs D., Imamura K., Rodriguez C., Horiguchi J., Kufe D. W. Induction of tumor necrosis factor expression and resistance in a human breast tumor cell line. Proc Natl Acad Sci U S A. 1987 Sep;84(18):6563–6566. doi: 10.1073/pnas.84.18.6563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Tamm I., Cardinale I., Krueger J., Murphy J. S., May L. T., Sehgal P. B. Interleukin 6 decreases cell-cell association and increases motility of ductal breast carcinoma cells. J Exp Med. 1989 Nov 1;170(5):1649–1669. doi: 10.1084/jem.170.5.1649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Warren M. K., Ralph P. Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony stimulating activity. J Immunol. 1986 Oct 1;137(7):2281–2285. [PubMed] [Google Scholar]
  47. Watson J. M., Sensintaffar J. L., Berek J. S., Martínez-Maza O. Constitutive production of interleukin 6 by ovarian cancer cell lines and by primary ovarian tumor cultures. Cancer Res. 1990 Nov 1;50(21):6959–6965. [PubMed] [Google Scholar]
  48. Welander C. E., Natale R. B., Lewis J. L., Jr In vitro growth stimulation of human ovarian cancer cells by xenogeneic peritoneal macrophages. J Natl Cancer Inst. 1982 Nov;69(5):1039–1047. [PubMed] [Google Scholar]
  49. Welch D. R., Fabra A., Nakajima M. Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc Natl Acad Sci U S A. 1990 Oct;87(19):7678–7682. doi: 10.1073/pnas.87.19.7678. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES